12th Conference on Retroviruses and Opportunistic Infections (CROI)

  1. Rosa María Resino García
  2. Rosa María Resino García
Journal:
HIV Clinical Trials

ISSN: 1528-4336,  1945-5771

Year of publication: 2005

Volume: 6

Issue: 3

Pages: 169-181

Type: Article

DOI: 10.1310/EYBU-95QU-J9JM-JC1E GOOGLE SCHOLAR lock_openOpen access editor

More publications in: HIV Clinical Trials

Bibliographic References

  • C. Tremblay and others. TAK-652, a novel small molecule in-hibitor of CCR5 has favorable anti-HIV interactions with other antiretroviralsin vitro. Abstract 542. 12th CROI. Feb-ruary 22–25, 2005. Boston, MA.